Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2014

Mar 4, 2014

29777_dirs_2014-03-04_6544cde1-d0f6-4dab-8953-4018efa75a34.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2014-02-28

Reporting Person: FREYMAN THOMAS C (Executive Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-02-28 Common shares without par value F 27660 $39.79 Disposed 314310 Direct
2014-03-03 Common shares without par value S 2984 $39.104 Disposed 311326 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common shares without par value 1076 Indirect
Common shares without par value 4000 Indirect
Common shares without par value 76000 Indirect
Common shares without par value 76000 Indirect
Common shares without par value 1941 Indirect
Common shares without par value 1941 Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of February 28, 2014.

F2: Held in the Annette Newton-Freyman 1994 Trust. The reporting person's spouse is trustee of the trust. The trust is revocable by his spouse. The reporting person disclaims beneficial ownership of these securities.

F3: Held in the Annette Newton-Freyman 2012 Irrevocable Trust. The reporting person is trustee of the trust. The trust is irrevocable. The reporting person disclaims beneficial ownership of these securities.

F4: Held in the Thomas C. Freyman 2012 Irrevocable Trust. The reporting person's spouse is trustee of the trust. The trust is irrevocable.

F5: The reporting person disclaims beneficial ownership of all securities held by his son.